secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyell Immunopharma, Inc. (LYEL)
CIK:        0001806952
Form:       8-K
Filed at:   2025-05-21T23:59:59+00:00
Accession:  0001193125-25-123970
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lyell shareholders elect Friedman, approve auditor, say-on-pay, and reverse split authorization up to 1-for-25
--------------------------------------------------------------------------------

- Class I director Catherine Friedman elected with 156.3M votes for (96.3% of votes cast).
- Ratification of Ernst & Young as auditor approved: 212.0M for, 0.3M against.
- Advisory say-on-pay passed with 160.7M votes for (99.0% of votes cast).
- Reverse stock split authorization approved: 199.9M for (94.2% of votes cast), ratio range 1:10 to 1:25 at Board's discretion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1806952/000119312525123970/0001193125-25-123970-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1806952/000119312525123970/d920680d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-123970

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer